Literature DB >> 29767848

Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms.

Nicole Kucine1, Mustafa Al-Kawaaz2, Daher Hajje2, James Bussel1, Attilio Orazi2.   

Abstract

Entities:  

Keywords:  essential thrombocythaemia; myeloproliferative neoplasm; paediatric haematology; polycythaemia vera

Mesh：

Substances：

Year:  2018        PMID： 29767848      PMCID： PMC6239998          DOI： 10.1111/bjh.15386

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  NORMAL VARIATIONS WITH AGING OF THE AMOUNT OF HEMATOPOIETIC TISSUE IN BONE MARROW FROM THE ANTERIOR ILIAC CREST. A STUDY MADE FROM 177 CASES OF SUDDEN DEATH EXAMINED BY NECROPSY.

Authors:  R J HARTSOCK; E B SMITH; C S PETTY
Journal:  Am J Clin Pathol       Date:  1965-04       Impact factor: 2.493

2.  Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

Authors:  Peter J Campbell; Linda M Scott; Georgina Buck; Keith Wheatley; Clare L East; Joanne T Marsden; Audrey Duffy; Elaine M Boyd; Anthony J Bench; Mike A Scott; George S Vassiliou; Donald W Milligan; Steve R Smith; Wendy N Erber; David Bareford; Bridget S Wilkins; John T Reilly; Claire N Harrison; Anthony R Green
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

3.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Authors:  Ross L Levine; Martha Wadleigh; Jan Cools; Benjamin L Ebert; Gerlinde Wernig; Brian J P Huntly; Titus J Boggon; Iwona Wlodarska; Jennifer J Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C Lee; Stacey Gabriel; Thomas Mercher; Alan D'Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A Mesa; Ayalew Tefferi; James D Griffin; Michael J Eck; William R Sellers; Matthew Meyerson; Todd R Golub; Stephanie J Lee; D Gary Gilliland
Journal:  Cancer Cell       Date:  2005-04       Impact factor: 31.743

4.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Authors:  E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; Soheila Swanton; George S Vassiliou; Anthony J Bench; Elaine M Boyd; Natasha Curtin; Mike A Scott; Wendy N Erber; Anthony R Green
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

6.  JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

Authors:  Elisa Rumi; Daniela Pietra; Virginia Ferretti; Thorsten Klampfl; Ashot S Harutyunyan; Jelena D Milosevic; Nicole C C Them; Tiina Berg; Chiara Elena; Ilaria C Casetti; Chiara Milanesi; Emanuela Sant'antonio; Marta Bellini; Elena Fugazza; Maria C Renna; Emanuela Boveri; Cesare Astori; Cristiana Pascutto; Robert Kralovics; Mario Cazzola
Journal:  Blood       Date:  2013-12-23       Impact factor: 22.113
  6 in total
  5 in total

1.  Clinical features associated with thrombotic events in children with myeloproliferative neoplasms.

Authors:  Kristin A Shimano; Victoria Vanderpoel; Hannah Stone; Linda Resar; Nicole Kucine
Journal:  Am J Hematol       Date:  2022-07-06       Impact factor: 13.265

Review 2.  Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults.

Authors:  Nicole Kucine
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

3.  Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia.

Authors:  Nicole Kucine; Shayla Bergmann; Spencer Krichevsky; Devin Jones; Michael Rytting; Juhi Jain; Carolyn M Bennett; Linda M S Resar; John Mascarenhas; Srdan Verstovsek; Ronald Hoffman
Journal:  Pediatr Blood Cancer       Date:  2020-12-31       Impact factor: 3.838

4.  EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.

Authors:  R J Leguit; A Orazi; N Kucine; H M Kvasnicka; U Gianelli; D A Arber; A Porwit; M Ponzoni
Journal:  Virchows Arch       Date:  2022-07-11       Impact factor: 4.535

5.  Children and Adolescents with Chronic Myeloproliferative Neoplasms: Still an Unmet Biological and Clinical Need?

Authors:  Tariq I Mughal; Michael W Deininger; Nicole Kucine; Giuseppe Saglio; Richard A Van Etten
Journal:  Hemasphere       Date:  2019-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.